nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achieving Good Metabolic Control Without Weight Gain with the Systematic Use of GLP-1-RAs and SGLT-2 Inhibitors in Type 2 Diabetes: A Machine-learning Projection Using Data from Clinical Practice
|
Giorda, Carlo Bruno |
|
|
45 |
8 |
p. 754-761 |
artikel |
2 |
Advancing Understanding of Inequities in Rare Disease Genomics
|
Serrano, Jillian G. |
|
|
45 |
8 |
p. 745-753 |
artikel |
3 |
Assessing Diversity in Newborn Genomic Sequencing Research Recruitment: Race/Ethnicity and Primary Spoken Language Variation in Eligibility, Enrollment, and Reasons for Declining
|
Cakici, Julie A. |
|
|
45 |
8 |
p. 736-744 |
artikel |
4 |
Assessing the Performance of the Clinician-reported Genetic Testing Utility InDEx (C-GUIDE): Further Evidence of Inter-rater Reliability
|
Hayeems, Robin Z. |
|
|
45 |
8 |
p. 729-735 |
artikel |
5 |
Cannabis Retail Market Indicators in Five Legal States in the United States: A Public Health Perspective
|
Dilley, Julia A. |
|
|
45 |
8 |
p. 778-786 |
artikel |
6 |
Conversations With the Editors: Stewardship in Genomic Medicine—Insights From Health Care Payers at the Forefront of Clinical Innovation and Partnerships
|
Smith, Hadley Stevens |
|
|
45 |
8 |
p. 690-694 |
artikel |
7 |
Defining Need Amid Exponential Change: Conceptual Challenges in Workforce Planning for Clinical Genetic Services
|
Borle, Kennedy |
|
|
45 |
8 |
p. 695-701 |
artikel |
8 |
Editorial Board
|
|
|
|
45 |
8 |
p. i-ii |
artikel |
9 |
Effect of the Dual Glucose‐Dependent Insulinotropic Peptide/Gulcagon‐like Peptide 1 Receptor Agonist Tirzepatide on Lipid Profile and Waist Circumference: A Systematic Review and Meta‐analysis
|
Yu, Dan |
|
|
45 |
8 |
p. 787-796 |
artikel |
10 |
Eliciting Societal Preferences for Non-health Outcomes: A Person Trade-Off Study in the Context of Genomics
|
Sheen, Daniel |
|
|
45 |
8 |
p. 710-718 |
artikel |
11 |
Fathoming the Role of Semaglutide in Obesity Therapeutics
|
George, Melvin |
|
|
45 |
8 |
p. 804-805 |
artikel |
12 |
Fezolinetant
|
Beninger, Paul |
|
|
45 |
8 |
p. 802-803 |
artikel |
13 |
Hyperlipoproteinemia (a) and Phytoestrogen Therapy in Dialysis Patients: A Review
|
Tabibi, Hadi |
|
|
45 |
8 |
p. e171-e175 |
artikel |
14 |
Navigating the Ethical Dilemmas Associated With Genomic Sequencing of the Newborn
|
Maron, Jill L. |
|
|
45 |
8 |
p. 685-686 |
artikel |
15 |
Parents’ Perspectives on Secondary Genetic Ancestry Findings in Pediatric Genomic Medicine
|
Richards, Jaimie L. |
|
|
45 |
8 |
p. 719-728 |
artikel |
16 |
Pediatric Genomic Medicine: Value, Implementation, and Access
|
Lavelle, Tara A. |
|
|
45 |
8 |
p. 687-689 |
artikel |
17 |
Persistence Among Patients with Crohn Disease Previously Treated with an Anti-tumor Necrosis Factor Inhibitor and Switching or Cycling to Another Biologic Agent
|
Zhdanava, Maryia |
|
|
45 |
8 |
p. 770-777 |
artikel |
18 |
Phage Therapy for Diabetic Foot Infection: A Case Series
|
Young, Matthew J. |
|
|
45 |
8 |
p. 797-801 |
artikel |
19 |
Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional Comparison
|
Zhao, Xiaoying |
|
|
45 |
8 |
p. 762-769 |
artikel |
20 |
Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions
|
Ungar, Wendy J. |
|
|
45 |
8 |
p. 702-709 |
artikel |